[
1. World Health Organization. Coronavirus disease 2019 (COVID-19). Situation report – 51. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200816-covid-19-sitrep-209.pdf
]Search in Google Scholar
[
2. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-CoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4)536-44.10.1038/s41564-020-0695-z709544832123347
]Search in Google Scholar
[
3. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223): 507-13.10.1016/S0140-6736(20)30211-7713507632007143
]Search in Google Scholar
[
4. Lu R, Zhao X, Li J, Niu P, Bo J, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224): 565-74.10.1016/S0140-6736(20)30251-8715908632007145
]Search in Google Scholar
[
5. Forster P, Forster L, Renfrew C, Forster M. Phylogenetic network analysis of SARSCoV-2 genomes. Proc Natl Acad Sci USA 2020;117(17):9241-43.10.1073/pnas.2004999117719676232269081
]Search in Google Scholar
[
6. Li F. Structure, function and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3(1):237–61.10.1146/annurev-virology-110615-042301545796227578435
]Search in Google Scholar
[
7. Walls A, Park Y, Tortorici M, Wall A, McGuire A, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281-92.10.1016/j.cell.2020.02.058710259932155444
]Search in Google Scholar
[
8. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARSCoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020;181(2):271-80.10.1016/j.cell.2020.02.052710262732142651
]Search in Google Scholar
[
9. Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Oude Munnink BB, et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science. 2020;368(6494):1012-15.10.1126/science.abb7314716467932303590
]Search in Google Scholar
[
10. Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251-54.10.1038/nature12005709532623486063
]Search in Google Scholar
[
11. Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-37.10.1002/path.1570716772015141377
]Search in Google Scholar
[
12. Santos RA, Ferreira AJ, Verano-Braga T, Bader M. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J Endocrinol. 2013;216(2):R1-R17.10.1530/JOE-12-034123092879
]Search in Google Scholar
[
13. Guy JL, Lambert DW, Warner FJ, Hooper NM, Turner AJ. Membrane-associated zinc peptidase families: comparing ACE and ACE2. Biochim Biophys Acta. 2005;1751(1):2-8.10.1016/j.bbapap.2004.10.010710524316054014
]Search in Google Scholar
[
14. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA. 2003;100(14):8258-63.10.1073/pnas.143286910016621612829792
]Search in Google Scholar
[
15. Horiuchi M, Akishita M, Dzau V. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension. 1999;33–2№:613-21.10.1161/01.HYP.33.2.613
]Search in Google Scholar
[
16. Kuba K, Imai Y, Ohto-Nakanishi T, Penninger J. Trilogy of ACE2: a peptidase in the reninangiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010;128(1):119-28.10.1016/j.pharmthera.2010.06.003711267820599443
]Search in Google Scholar
[
17. Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24(1):422-26.10.1186/s13054-020-03120-0735613732660650
]Search in Google Scholar
[
18. Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170(4):1136-47.10.2353/ajpath.2007.061088182944817392154
]Search in Google Scholar
[
19. Alsaad KO, Hajeer AH, Al Balwi M, Al Moaiqel M, Al Oudah N, Al Ajlan A, et al. Histopathology of Middle East Respiratory Syndrome coronovirus (MERS-CoV) infection-clinicopathological and ultrastructural study. Histopathology. 2018;72(3):516-24.10.1111/his.13379716551228858401
]Search in Google Scholar
[
20. Wei L, Sun S; Zhang J; Zhu H; Xu Y; Ma Q, et al. Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS). Biochem Cell Biol. 2010;88(4):723-30.10.1139/O10-02220651845
]Search in Google Scholar
[
21. Lisco G, Tullio A, Stragapede A, Solimando A, Albanese F, Capobianco М, et al. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme. J Clin Med.2021;10(13):2920-27.10.3390/jcm10132920826933134209964
]Search in Google Scholar
[
22. Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):327-31.
]Search in Google Scholar
